Brinda Alagesan

3PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 13, 2026
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.

Brinda Alagesan, Anna M Varghese, Celina Ang

|May 22, 2021
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.

Derek K Cheng, Tobiloba E Oni, Jennifer S Thalappillil

|Jun 22, 2019
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.

Dannielle D Engle, Hervé Tiriac, Keith D Rivera

Pageof 1